Net Income for Bristol-Myers Squibb (BMY)
According to Bristol-Myers Squibb's latest reported financial statements, the company's current net income (TTM) is $7.05B USD. Net income is the bottom-line profit after all expenses — cost of goods sold, operating expenses, interest, and taxes — are subtracted from revenue. It is the figure used to compute earnings per share (EPS) and is the residual available to shareholders.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
Currently viewingNet IncomeSwitch metric
TTM (last 4 quarters)
$7.05B
YoY change
-178.8%
5Y CAGR
N/A
Peak year (2009)
$10.61B
Cumulative net income
$106.78B
Net Income history chart for Bristol-Myers Squibb (BMY) from 1987 to 2025
Net Income history table for Bristol-Myers Squibb (BMY) from 1987 to 2025
| Fiscal year | Period ended | Reported | Net Income | YoY |
|---|---|---|---|---|
| 2025 | $7.05B | -178.8% | ||
| 2024 | -$8.95B | -211.5% | ||
| 2023 | $8.03B | +26.8% | ||
| 2022 | $6.33B | -9.5% | ||
| 2021 | $6.99B | -177.8% | ||
| 2020 | -$8.99B | -361.6% | ||
| 2019 | $3.44B | -30.1% | ||
| 2018 | $4.92B | +388.6% | ||
| 2017 | $1.01B | -77.4% | ||
| 2016 | $4.46B | +184.8% | ||
| 2015 | $1.56B | -21.9% | ||
| 2014 | $2.00B | -21.8% | ||
| 2013 | $2.56B | +30.8% | ||
| 2012 | $1.96B | -47.2% | ||
| 2011 | $3.71B | +19.6% | ||
| 2010 | $3.10B | -70.8% | ||
| 2009 | $10.61B | +102.2% | ||
| 2008 | $5.25B | +142.4% | ||
| 2007 | $2.17B | +36.6% | ||
| 2006 | $1.58B | -47.2% | ||
| 2005 | $3.00B | +25.6% | ||
| 2004 | $2.39B | -23.1% | ||
| 2003 | $3.11B | +45.3% | ||
| 2002 | $2.14B | -55.8% | ||
| 2001 | $4.83B | +2.6% | ||
| 2000 | $4.71B | +13.1% | ||
| 1999 | $4.17B | +32.7% | ||
| 1998 | $3.14B | -2.0% | ||
| 1997 | $3.21B | +12.5% | ||
| 1996 | $2.85B | +57.3% | ||
| 1995 | $1.81B | -1.6% | ||
| 1994 | $1.84B | -6.0% | ||
| 1993 | $1.96B | -0.2% | ||
| 1992 | $1.96B | -4.6% | ||
| 1991 | $2.06B | +17.6% | ||
| 1990 | $1.75B | +134.0% | ||
| 1989 | $747.00M | -40.4% | ||
| 1988 | $1.25B | +17.4% | ||
| 1987 | $1.07B | — |
Net Income values are taken from Bristol-Myers Squibb's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
2025's annual net income for Bristol-Myers Squibb (BMY) came in at $7.05B – plunged 178.8% year-over-year.
Across 2015–2025 (10 years), Bristol-Myers Squibb net income produced a CAGR of +16.2% – with the latest reading among the more recent periods of the dataset.
Bristol-Myers Squibb net income peaked at $10.61B in 2009; the latest annual figure is $7.05B in 2025 (33.5% below peak).
$10.61B stands as the all-time-high annual net income, posted in 2009, against a low of -$8.99B during 2020.
Bristol-Myers Squibb (BMY) sits 8th of 8 Healthcare peers we track on this metric, against a peer median of $15.15B.
Bristol-Myers Squibb Net Income by Year
Bristol-Myers Squibb Net Income 2025: $7.05B
Bristol-Myers Squibb net income in 2025 was $7.05B, plunged 178.8% below 2024.
Bristol-Myers Squibb Net Income 2024: -$8.95B
Bristol-Myers Squibb net income in 2024 was -$8.95B, plunged 211.5% below 2023.
Bristol-Myers Squibb Net Income 2023: $8.03B
Bristol-Myers Squibb net income in 2023 was $8.03B, grew 26.8% from 2022.
Bristol-Myers Squibb Net Income 2022: $6.33B
Bristol-Myers Squibb net income in 2022 was $6.33B, declined 9.5% below 2021.
Bristol-Myers Squibb Net Income 2021: $6.99B
Bristol-Myers Squibb net income in 2021 was $6.99B.
See more financial history for Bristol-Myers Squibb (BMY).
Sector peers — Net Income
Companies in the same sector as Bristol-Myers Squibb, ranked by their latest net income.
| Company | Net Income | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $102.43B | Healthcare |
| Johnson & Johnson (JNJ) | $26.80B | Healthcare |
| Eli Lilly and Company (LLY) | $20.64B | Healthcare |
| Merck & Co., Inc. (MRK) | $18.25B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $12.06B | Healthcare |
| AstraZeneca PLC (AZN) | $10.26B | Healthcare |
| Amgen Inc. (AMGN) | $7.71B | Healthcare |
| AbbVie Inc. (ABBV) | $4.23B | Healthcare |
Frequently asked questions
What is Bristol-Myers Squibb's net income?
- Latest reported net income for Bristol-Myers Squibb (BMY) is $7.05B (period ending December 31, 2025).
How has Bristol-Myers Squibb net income changed year-over-year?
- Bristol-Myers Squibb (BMY) net income changed -178.8% year-over-year on the latest annual filing.
What is the long-term growth rate of Bristol-Myers Squibb net income?
- Bristol-Myers Squibb (BMY) net income compound annual growth rate is +16.2% over the most recent 10 years available.
When did Bristol-Myers Squibb net income hit its highest annual value?
- Bristol-Myers Squibb net income reached its highest annual value of $10.61B in 2009.
What was Bristol-Myers Squibb net income in 2024?
- Bristol-Myers Squibb (BMY) net income in 2024 was -$8.95B.
What was Bristol-Myers Squibb net income in 2025?
- Bristol-Myers Squibb (BMY) net income in 2025 was $7.05B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
BMY Overview
Company profile, financial tools, and key metrics
BMY Revenue Counter
Earns $1,528 every second. See per minute, hour, and day.
BMY Earnings Counter
Earns $223.65 per second net profit. See per minute, hour, and day.
BMY Economic Scale
Exceeds Bahrain's GDP. Compare with world economies.
BMY What If Invested
What if you had invested $1,000? See historical returns from any date.
BMY How It Makes Money
Discover visual breakdown of $48.19B in revenue — where it comes from and where it goes.
BMY Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
BMY Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
BMY Daily Price Character
Steady · 47.3% historical win rate (green days). Streaks & record days.
BMY Buybacks
Recent repurchase activity. Shareholder yield & SBC comparison.
BMY Stock Split History
6 splits on record. Dates, ratios, and cumulative multiple.
BMY Dividend Profile
Yield: 4.34%. Safety: 7/8. See full history.
BMY Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
BMY Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.